{"id":45433,"date":"2022-06-23T17:01:41","date_gmt":"2022-06-23T15:01:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/"},"modified":"2022-06-23T17:01:41","modified_gmt":"2022-06-23T15:01:41","slug":"pfizer-declares-third-quarter-2022-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/","title":{"rendered":"Pfizer Declares Third-Quarter 2022 Dividend"},"content":{"rendered":"
\n

\nBoard of Directors approves quarterly cash dividend of $0.40 per share<\/i><\/b>\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 third-quarter 2022 dividend on the company\u2019s common stock, payable September 6, 2022, to holders of the Common Stock of record at the close of business on July 29, 2022. The third-quarter 2022 cash dividend will be the 335th consecutive quarterly dividend paid by Pfizer.\n<\/p>\n

<\/a><\/p>\n

\nAbout Pfizer: Breakthroughs That Change Patients\u2019 Lives<\/b><\/i>\n<\/p>\n

\nAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com<\/a>. In addition, to learn more, please visit us on www.Pfizer.com<\/a> and follow us on Twitter at @Pfizer<\/a> and @Pfizer News<\/a>, LinkedIn<\/a>, YouTube<\/a> and like us on Facebook at Facebook.com\/Pfizer<\/a>.\n<\/p>\n

\nCategory: Finance\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
PfizerMediaRelations@Pfizer.com<\/a>
+1 (212) 733-1226<\/p>\n

Investor Contact:
\n
IR@Pfizer.com<\/a>
+1 (212) 733-4848\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Board of Directors approves quarterly cash dividend of $0.40 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 third-quarter 2022 dividend on the company\u2019s common stock, payable September 6, 2022, to holders of the Common Stock of record at the close of business on July 29, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45433","6":"format-standard","7":"category-industry"},"yoast_head":"\nPfizer Declares Third-Quarter 2022 Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Declares Third-Quarter 2022 Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Board of Directors approves quarterly cash dividend of $0.40 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 third-quarter 2022 dividend on the company\u2019s common stock, payable September 6, 2022, to holders of the Common Stock of record at the close of business on July 29, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-23T15:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220622005761\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pfizer Declares Third-Quarter 2022 Dividend\",\"datePublished\":\"2022-06-23T15:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005761\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/\",\"name\":\"Pfizer Declares Third-Quarter 2022 Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005761\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"datePublished\":\"2022-06-23T15:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005761\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005761\\\/en\\\/1045874\\\/21\\\/Pfizer_Logo_Color_RGB_APPROVED.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pfizer-declares-third-quarter-2022-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Declares Third-Quarter 2022 Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Declares Third-Quarter 2022 Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Declares Third-Quarter 2022 Dividend - Pharma Trend","og_description":"Board of Directors approves quarterly cash dividend of $0.40 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 third-quarter 2022 dividend on the company\u2019s common stock, payable September 6, 2022, to holders of the Common Stock of record at the close of business on July 29, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-23T15:01:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220622005761\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pfizer Declares Third-Quarter 2022 Dividend","datePublished":"2022-06-23T15:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/"},"wordCount":269,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220622005761\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/","url":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/","name":"Pfizer Declares Third-Quarter 2022 Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220622005761\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","datePublished":"2022-06-23T15:01:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220622005761\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220622005761\/en\/1045874\/21\/Pfizer_Logo_Color_RGB_APPROVED.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pfizer-declares-third-quarter-2022-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pfizer Declares Third-Quarter 2022 Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45433"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45433\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}